Reported Standalone quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 93.86 crore in December 2024 up 84.78% from Rs. 50.79 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 40.40 crore in December 2024 down 65.94% from Rs. 24.35 crore in December 2023.
EBITDA stands negative at Rs. 3.84 crore in December 2024 up 77.97% from Rs. 17.43 crore in December 2023.
Astec Life shares closed at 914.30 on January 24, 2025 (NSE) and has given -27.83% returns over the last 6 months and -4.66% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 93.86 | 98.55 | 50.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 93.86 | 98.55 | 50.79 | | EXPENDITURE | | Consumption of Raw Materials | 63.31 | 66.38 | 43.17 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -1.73 | 13.85 | -7.85 | | Power & Fuel | -- | -- | -- | | Employees Cost | 15.52 | 14.93 | 14.43 | | Depreciation | 11.42 | 11.49 | 8.72 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 22.50 | 23.12 | 19.37 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -17.15 | -31.22 | -27.05 | | Other Income | 1.89 | 1.98 | 0.90 | | P/L Before Int., Excpt. Items & Tax | -15.26 | -29.24 | -26.15 | | Interest | 9.92 | 9.34 | 6.10 | | P/L Before Exceptional Items & Tax | -25.18 | -38.57 | -32.25 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -25.18 | -38.57 | -32.25 | | Tax | 15.22 | -- | -7.90 | | P/L After Tax from Ordinary Activities | -40.40 | -38.57 | -24.35 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -40.40 | -38.57 | -24.35 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -20.60 | -19.67 | -12.42 | | Diluted EPS | -20.60 | -19.67 | -12.42 | | EPS After Extra Ordinary | | Basic EPS | -20.60 | -19.67 | -12.42 | | Diluted EPS | -20.60 | -19.67 | -12.42 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
